摘要
目的通过对门诊与住院治疗精神分裂症患者的病耻感评估,分析不同治疗环境对精神分裂症病耻感的影响。方法对浙江省立同德医院门诊和住院治疗的缓解期精神分裂症患者各70例进行人口学特征、精神病简明评定量表(BPRS)、PANSS量表、副反应量表、临床疗效总评量表严重度(CGI-SI)和病耻感量表进行测量和评估,比较门诊与住院患者缓解期病耻感特点。结果两组精神分裂症患者普遍存在被歧视、自我感觉的病耻感及对疾病的掩饰性,但经过住院治疗的患者对病耻感的掩饰性因子(2.01±0.88)分和积极效应因子(1.68±0.78)分低于门诊治疗的患者(2.43±0.98)和(2.44±0.78)分,差异均有统计学意义(P<0.05)。结论门诊治疗对减轻耻感、提高生活质量相当重要。严格遵守和执行精神卫生法,可以较大限度地保护精神病患者的合法权益。
Objective To analyze the influence of different therapeutic environments on stigma of schizophrenia patients.Methods A total of 70 outpatients and 70 inpatients with schizophrenia in remission in Tongde hospital of Zhejiang province were enrolled and investigated by using Brief Psychiatric Rating Scale( BPRS),Positive and Negative Syndrome Scale( PANSS),Treatment Emergent Symptom Scale( TESS) and Clinician's Global Impressions- Severity of Illness Scale( CGI-SI). Results Both outpatients and inpatients had been discriminated and had the situation of stigma and disease concealing. After inpatient treatment,the scores of disease concealing factor and positive effect factor were 2. 01 ± 0. 88 and1. 68 ± 0. 78 respectively,which were significantly lower than those of outpatients( 2. 43 ± 0. 98 and 2. 44 ± 0. 78,respectively,P〈 0.05). Conclusion Outpatient treatment has the influence on reduce stigma and improve the life quality of schizophrenia patients in remission.
出处
《浙江预防医学》
2014年第9期893-896,共4页
Zhejiang Journal of Preventive Medicine
基金
2010神经精神转化医学科技创新团队项目资助(2010R50049)
浙江省医药卫生科技项目(2012KYA039)